Back

Results - Announcements

Sales rise 17.90% to Rs 949.42 crore

Glaxosmithkline Pharmaceuticals consolidated net profit rises 402.80% in the December 2024 quarter

14-Feb-2025, 05:57
Net profit of Glaxosmithkline Pharmaceuticals rose 402.80% to Rs 229.88 crore in the quarter ended December 2024 as against Rs 45.72 crore during the previous quarter ended December 2023. Sales rose 17.90% to Rs 949.42 crore in the quarter ended December 2024 as against Rs 805.26 crore during the previous quarter ended December 2023.

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	949.42	805.26	18
OPM %	30.75	27.08	-
PBDT	326.90	245.85	33
PBT	308.10	228.74	35
NP	229.88	45.72	403